News releases
Date
Language

Type of release


Download

Full announcement
Feb 05, 2013

Previously announced FDA Warning Letter published

Bagsværd, Denmark, 5 February 2013 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has published the Warning Letter, which the company mentioned in its Financial Statement for 2012 on 31 January.

Further information

Media:
Mike Rulis +45 3079 3573 mike@novonordisk.com
Lori Moore +1 609 919 7991 lrmo@novonordisk.com
Investors:
Kasper Roseeuw Poulsen +45 4442 4303 krop@novonordisk.com
Frank Daniel Mersebach +45 4442 0604 fdni@novonordisk.com
Lars Borup Jacobsen +45 3075 3479 lbpj@novonordisk.com
Jannick Lindegaard (US) +1 609 786 4575 jlis@novonordisk.com

Company announcement No 10 / 2013